Maureen Deehan
Amministratore Delegato presso Vivtex Corp.
Profilo
Maureen Deehan is currently the Chief Executive Officer at Vivtex Corp.
She previously worked at Nordic Nanovector ASA as the Head of Corporate Development & Strategy.
She completed her undergraduate degree at the University of Strathclyde and holds a doctorate from the University of Glasgow School of Medicine.
Posizioni attive di Maureen Deehan
| Società | Posizione | Inizio |
|---|---|---|
| Vivtex Corp. | Amministratore Delegato | 21/02/2023 |
Precedenti posizioni note di Maureen Deehan
| Società | Posizione | Fine |
|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | - |
Formazione di Maureen Deehan
| University of Strathclyde | Undergraduate Degree |
| University of Glasgow School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Borsa valori
- Insiders
- Maureen Deehan
